Find a TenderAwarded

Published 17 Sept 2024, 14:58 BST

Official UK procurement notice

Biologic and Biosimilar Medicines

Official notice

Authority: eTenderwales·Consortium: 2 public authorities

2 lotsGoodsOpen procedure

Sectors: Medical Devices & Pharma (33) Delivery: UKWales (UKL)

Published estimate£70,828,856total for 2 lots

Submissions closed 18 Oct 2024awarded 23 Apr 2025

Awarded to Abbvie Ltd +9 more10 awards

Contract term 3 yrsends 30 Jun 2028 · extension options published · starts 1 Jul 2025

What is being bought2 lots · detail below

Published requirement description

Biologic and Biosimilar Medicines

CPV: Pharmaceutical products

Lots and requirements (2)Procurement structure

2 lots · all with a published value (£70,828,856 together)

Lot #1Homecare Multi SupplierAwardedRenewal 3 yrsPublished value£62,828,856

Biosimilars and Biologics

Contract period: 1 Jul 2025 – 30 Jun 2028 (3 yrs)

Delivery: UK, Wales

Extensions: Retendered after 3 year contract with an option to extend for 12monthsVariant bids: allowed

33600000 Pharmaceutical products

Lot #2RituximabRenewal 3 yrsPublished value£8,000,000

Procurement for the provision of Rituximab.

Contract period: 1 Jul 2025 – 30 Jun 2028 (3 yrs)

Delivery: UK, Wales

Extensions: Retendered after 3 year contract with an option to extend for 12monthsVariant bids: allowed

33600000 Pharmaceutical products

What it takes to win
i
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).

Evaluation split and conditions of participation as published; the tender pack may add more

How bids were scored

Price: 85%Social value: 15%

Published award criteria (3)

Quality: Pass/Fail
Social Value: 15
Price: 85

Conditions of participation1

Suitability
Any supplier may be disqualified who does not respond to the following in the
requisite manner:
1. ENTERING GENERAL Qualification SUPPLIER INFORMATION NHS Wales Shared Services Partnership Procurement Services utilizes Sell2Wales to manage and assess general prequalification information in the form of a profile.
Candidates are requested to Register company information on the Sell2Wales website at ww.sell2wales.co.uk.
1. SUBMISSION OF TENDER AND PROCUREMENT SPECIFIC INFORMATION
(i)Candidates should register on the NHS Wales Shared Services Partnership Procurement Services eTendering portal etenderwales.bravosolution.co.uk/nhs ↗
(ii) Once registered, candidates must submit their tender as follows a) login to NHS Wales Shared Services Partnership Procurement Services eTendering portal b) select 'Respond to OJEU advert and ITT c) select 'ITTs Open To All Suppliers' d) access listing relating to the contract (title Lenalidomide) and view details e) click on 'Express Interest' button in the 'Actions' box on the left hand side of the page
(iii) Once you have expressed interest, the ITT will move to 'My ITTs', where you can download additional documentation and where you can construct your reply as instructed. You must then publish your reply using the publish button
(iv) For any support in submitting your tender, please contact the eTendering helpdesk on 08000112470 or at [email protected]

What this means for your bid

Price carries 85 of 100 points: a 10% discount moves about 8.5 points. This one is won on the number: sharpen the price before polishing the prose.

Price arithmetic assumes straight proportional scoring; the tender pack may use another formula.

Procedure terms & legal framework

From the official record · publisher note attached

Procedure method: Open procedure
Legal basis: CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
Procurement category: Goods
Notice status: Awarded
Procurement threshold: Unspecified in notice
Regulatory regime: Standard
Commercial structure: Stand-alone contract (no framework)
Competition type: Competitive procedure
GPA / WTO covered: Unspecified in notice
Recurring procurement: Yes
First published: 17 Sept 2024, 14:58 BST
Last source update: 21 May 2025, 16:24 BST
Award evaluation window: 18 Oct 2024 – …
Authority reference: PAD-OJEU-56923
FTS notice number: 2025/S 000-024261
Classification (CPV): Pharmaceutical products
Delivery area: UKWales (UKL)
Official registry OCID: ocds-h6vhtk-049b93 Find a Tender

Publisher note: 1. The contracting authority reserves the right to use an electronic reverse auction. 2. If and when this requirement is offered for tender, this may be done in whole or in part via electronic means using the internet. 3. The contracting authority is not bound to award a contract in whole or part. 4. The contracting authority will not bear the tender costs of any of the tenderers. 5. In reference to I.1.9 (Variants) to the extent permitted, if at all, in the tender documents. 6. This notice is being placed by NHS Wales Shared Services Partnership – Procurement Services. For the purpose of this procurement, the awarding authority will be Velindre NHS Trust. 7. This advertisement is placed by NHS Wales Shared Services Partnership - Procurement Services on behalf of participating LHB's/Trusts in Wales for the totality of those LHB/Trust specific contractual arrangements. 8. The Framework to be let for 3 years with an option to extend for 12months

How it was run

Official notice

Run through: Jaggaer · Who buys & how to bid on Sell2Wales

Supplier login requiredLanguage: EN

Access & registration note: Free; latest Chrome/Edge/Firefox only — corporate browsers fail

Tender documents are also served through a separate tool: http://www.etenderwales.bravosolution.co.uk/nhs/ ↗

Submission deadline: 18 Oct 2024, 12:00 BST
Submission channel: {"electronicSubmission","written"}
Accepted languages: en
Participation fee: document
Bids opened: 18 Oct 2024, 12:01 BST

Detailed submission instructions & authority contactsFrom official release

www.etenderwales.bravosolution.co.uk/nhs/ ↗

Timeline

18 Oct 2024 → 1 Jul 2025 · 4 dates

Submission deadline
18 Oct 2024, 12:00 BST
Bids opened
18 Oct 2024, 12:01 BST
Notice published
21 May 2025, 16:24 BST
Contract starts
1 Jul 2025, 00:00 BST

Notice history

2 events · 2 releases on Find a Tender · since 21 May 2025

Status changed to complete
21 May 2025, 16:24 BST
Buyer details updated
21 May 2025, 16:24 BST

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast

Awards 19

Awarded value £96,642,40019 contracts exc. VAT

Bids received 19

Contracts signed 19latest 23 Apr 2025

Awarded to	Value	Date	Status
Lot 1 · Homecare Multi Supplier10 awards
Abbvie Ltd	£4,100,400 †	—	Awarded
Gedeon Richter UK Ltd	£1,944,200 †	—	Awarded
Janssen-Cilag Ltd	£555,400 †	—	Awarded
Organon Pharmaceuticals UK Ltd	£89,600 †	—	Awarded
Pfizer Ltd	£5,690,000 †	—	Awarded
Roche Products Ltd	£44,412,000 †	—	Awarded
Sandoz	£540,200 †	—	Awarded
Sun Pharma UK Ltd	£60,800 †	—	Awarded
Thornton and Ross Ltd	£502,000 †	—	Awarded
Teva UK Ltd	£49,200 †	—	Awarded

9 further award records carry no date or value.

Contracts

Biologic and Biosimilar Medicines · Abbvie Ltd
Signed
23 Apr 2025
Value
£4,100,400
Period
… – 30 Jun 2028
Status
active
Biologic and Biosimilar Medicines · Gedeon Richter UK Ltd
Signed
23 Apr 2025
Value
£1,944,200
Period
… – 30 Jun 2028
Status
active
Biologic and Biosimilar Medicines · Janssen-Cilag Ltd
Signed
23 Apr 2025
Value
£555,400
Period
… – 30 Jun 2028
Status
active
Biologic and Biosimilar Medicines · Organon Pharmaceuticals UK Ltd
Signed
23 Apr 2025
Value
£89,600
Period
… – 30 Jun 2028
Status
active
Biologic and Biosimilar Medicines · Pfizer Ltd
Signed
23 Apr 2025
Value
£5,690,000
Period
… – 30 Jun 2028
Status
active
Biologic and Biosimilar Medicines · Roche Products Ltd
Signed
23 Apr 2025
Value
£44,412,000
Period
… – 30 Jun 2028
Status
active
Biologic and Biosimilar Medicines · Sandoz
Signed
23 Apr 2025
Value
£540,200
Period
… – 30 Jun 2028
Status
active
Biologic and Biosimilar Medicines · Sun Pharma UK Ltd
Signed
23 Apr 2025
Value
£60,800
Period
… – 30 Jun 2028
Status
active
Biologic and Biosimilar Medicines · Thornton and Ross Ltd
Signed
23 Apr 2025
Value
£502,000
Period
… – 30 Jun 2028
Status
active
Biologic and Biosimilar Medicines · Teva UK Ltd
Signed
23 Apr 2025
Value
£49,200
Period
… – 30 Jun 2028
Status
active
Biologic and Biosimilar Medicines
Signed
23 Apr 2025
Value
£60,600
Period
… – 30 Jun 2028
Status
active
Biologic and Biosimilar Medicines
Signed
23 Apr 2025
Value
£90,800
Period
… – 30 Jun 2028
Status
active
Biologic and Biosimilar Medicines
Signed
23 Apr 2025
Value
£8,750,400
Period
… – 30 Jun 2028
Status
active
Biologic and Biosimilar Medicines
Signed
23 Apr 2025
Value
£23,169,600
Period
… – 30 Jun 2028
Status
active
Biologic and Biosimilar Medicines
Signed
23 Apr 2025
Value
£54,000
Period
… – 30 Jun 2028
Status
active
Biologic and Biosimilar Medicines
Signed
23 Apr 2025
Value
£6,481,800
Period
… – 30 Jun 2028
Status
active
Biologic and Biosimilar Medicines
Signed
23 Apr 2025
Value
£52,200
Period
… – 30 Jun 2028
Status
active
Biologic and Biosimilar Medicines
Signed
23 Apr 2025
Value
£16,400
Period
… – 30 Jun 2028
Status
active
Biologic and Biosimilar Medicines
Signed
23 Apr 2025
Value
£22,800
Period
… – 30 Jun 2028
Status
active

Bid statistics published by the authority

Lot	Bids	SME	VCSE	Valid bid range
1 · Homecare Multi Supplier	19bids	—	—	—

Contracting authority & participating public bodies

2 public bodies on the notice

eTenderwales

Contracting authorityBody governed by public lawHealth Ty' r Afon Bedwas Road, Newport, Wales, NP10 8BEContact name, email, phone

Consortium members and other public bodies

Velindre NHS Trust, NHS Shared Services Partnership - Procurement Services (on behalf of All Wales Health Boards and Trusts)Contracting authorityCentral purchasing bodyBody governed by public lawHealth Newport, UKContact name, email, phone Published organisation website ↗

Dispute resolution & review bodies

NHS Wales Shared Services Partnership - Procurement Services (as hosted by Velindre NHS Trust)Review body Newport
Velindre NHS Trust, NHS Wales Shared Services Partnership — Procurement Services (on behalf of All Wales LHB's and TrustsReview body Newport

Bidders & participating suppliers

19 commercial parties on the notice

Abbvie LtdAwarded supplier Maidenhead, UK
Accord-UK LtdAwarded supplier Barnstaple, UK
Amgen LtdAwarded supplier Cambridge, UK
Biogen Idec LimitedAwarded supplier Maidenhead, UK
Biosimilar Collaborations Ireland LimitedAwarded supplier Dublin, UK
Celltrion Healthcare United Kingdom LimitedAwarded supplier Uxbridge, UK
Dr Reddy'sAwarded supplier Cambridge, UK
Eli Lilly and Company LimitedAwarded supplier Basingstoke, UK
Fresenius Kabi LtdAwarded supplier Runcorn, UK
Gedeon Richter (UK) LImitedAwarded supplier London, UK

Show 9 more suppliers

Janssen-Cilag LtdAwarded supplier Buckinghamshire, UK
Organon Pharmaceuticals UK LtdAwarded supplier London, UK
Pfizer LtdAwarded supplier Tadworth, UK
Roche Products LtdAwarded supplier Welwyn Garden City, UK
Sandoz LtdAwarded supplier Camberley, UK
Sun Pharma UK LtdAwarded supplier Uxbridge, UK
Teva UK LtdAwarded supplier Castleford, UK
Thornton & Ross LtdAwarded supplier Linthwaite, UK
Zentiva Pharma UK LimitedAwarded supplier Guilford, UK

Official documents & specifications (2)

Official links; attachments are not copied

Tender pack and attachments

Economic and financial selection criteriatenderEconomic and financial selection criteria
Technical selection criteriatenderTechnical selection criteria